Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: a pooled analysis of individual patient data from three randomized trials-Reference-Cited by-全球学者库

Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: a pooled analysis of individual patient data from three randomized trials

Published:2023-12-25 Issue: Volume: Page:
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Guo Tiantian¹²³⁴,Zhou Yue¹²³⁴,Liang Fei⁵,Wang Zezhou²⁶,Bourbonne Vincent⁷,Käsmann Lukas⁸,Sundahl Nora⁹,Jing‐Ching Wu Abraham¹⁰,Ni Jianjiao¹²³⁴,Zhu Zhengfei¹²³⁴¹¹^ORCID

Affiliation:

1. Department of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai P. R. China

2. Department of Oncology Shanghai Medical College, Fudan University Shanghai P. R. China

3. Shanghai Clinical Research Center for Radiation Oncology Shanghai P. R. China

4. Shanghai Key Laboratory of Radiation Oncology Shanghai P. R. China

5. Department of Biostatistics Zhongshan Hospital, Fudan University Shanghai P. R. China

6. Department of Cancer Prevention Fudan University Shanghai Cancer Center Shanghai P. R. China

7. Radiation Oncology Department University Hospital Brest France

8. Department of Radiation Oncology University Hospital, LMU Munich Munich Germany

9. Department of Radiation Oncology AZ Groeninge Kortrijk Belgium

10. Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York USA

11. Institute of Thoracic Oncology, Fudan University Shanghai P. R. China

Funder

Chinese Society of Clinical Oncology

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12512

Reference10 articles.

1. Management of Brain Metastases in Non–Small-Cell Lung Cancer

2. Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

3. Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data

4. Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer

5. Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy